S&P 500 7,811.54 +0.59%Nasdaq 27,366.17 +0.64%Dow 51,654.95 +0.83%Russell 2000 2,806.98 +0.46%as of 2026-10-09 close
▚ The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd
Deals & FilingsSponsored

27 Startups. One Ticker. How Scalare Partners (ASX: SCP) Turned a Founder Pipeline Into a Listed Portfolio

Scalare sees Australia's best early-stage founders before anyone else does. Then it invests. Then it lodges the numbers. Read them before the crowd.
Sponsored content · Scalare Partners (ASX: SCP) via SGNL Media
Illustrative photograph: people working in a business setting.

Deal flow is the whole game in early-stage investing. Everyone can write a cheque. Almost nobody sees the right companies first. Scalare Partners (ASX: SCP) built its entire model around being the one that does.

Scalare operates Tank Stream Labs and Fishburners, founder communities that provide workspace, programs and services to early-stage technology companies across Australia. Founders arrive for the support. Scalare gets something no outside investor can buy: months of watching those founders work before a single dollar is invested. Its investments are sourced from inside that ecosystem.

The result is a portfolio of 27 early-stage technology companies across six categories, fintech, healthtech, regtech, cleantech, SaaS and AI, as at 31 December 2025. Named holdings include WithU, MyPass, CHI and Zondii.

And unlike a venture fund, the pipeline itself earns money. Revenue and other income up 360% on the prior corresponding period for the half-year to 31 December 2025, per the Appendix 4D lodged with the ASX on 27 February 2026. Includes revenue from businesses acquired during the period; growth was materially acquisition-driven, with Tank Stream Labs around 73% of service revenue. Past performance is not a reliable indicator of future performance. The full filing is on the ASX announcements platform under SCP.

That is the part institutions understand and retail is only now catching up to: the founder communities are not a cost centre, they are a revenue line and a sourcing machine in the same building.

This is how the big end of town has always invested in technology: see the company early, back it early, own it when the rest of the market arrives. Scalare has put that model on the ASX under one code. Shares are traded on the ASX, subject to market liquidity.

The investor brief lays out the pipeline, the portfolio and the lodged number in one place. Free, two minutes, built from the filings.

Read the free investor brief
Free. Built from ASX-lodged filings. One email, no fund, no lock-up.
This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage

Illustrative photograph: US banknotes and coins.
Deals & Filings

Sadot Group Signed Two Deals on Sept. 30 With $124,000 of Cash at Mid-Year: a Software Purchase With a $7.45 Million Stated Value, Paid Mostly in Preferred That Converts at $13 Only if Nasdaq Confirms It Is Not a Reverse Merger, and a $7.8 Million Joint-Venture Pledge

Two 8-Ks filed Oct. 1 show the Nasdaq-listed former restaurant operator paying $300,000 cash plus 7,150 contingently convertible preferred shares for the SalesIQ platform, and committing $7,814,323 to a 50/50 venture with VisionWave Holdings. Its June 30 10-Q reported a $13.6 million working capital deficit and substantial doubt about going-concern status.

Adam Kowalczyk · October 10, 2026
Illustrative photograph: US banknotes and coins.
Deals & Filings

Arrive AI's $250,000 'Registered Direct' at a 213% Premium Was a PIPE, Its 8-K Says, and the Attached Warrant Converts Cashlessly Into 3.33 Shares for Every One

The Nasdaq-listed delivery-infrastructure company sold 384,615 shares and a matching warrant to one investor at $0.65, then corrected a press release that had called the sale a registered direct offering. The warrant's cashless-exercise clause, available at all times, delivers 3.33 shares per warrant share without payment.

Adam Kowalczyk · October 10, 2026
Illustrative photograph: laboratory research equipment.
Deals & Filings

Nexalin Cleared the First of Two Nasdaq Panel Conditions on Sept. 30; the Second Requires $2.5 Million of Stockholders' Equity by Jan. 4, 2027, Against $1.52 Million Reported at June 30

A Nasdaq Hearings Panel let the neurostimulation company stay listed on two conditions: a $1.00 bid price by Sept. 28 and $2.5 million of equity by Jan. 4, 2027. A 1-for-30 reverse split and an ATM raise of about $1.9 million have addressed the first; the June 30 balance sheet showed $1,519,423 of equity.

Jonas Halvorsen · October 10, 2026